Axsome Therapeutics Inc (NASDAQ:AXSM)

26.46
Delayed Data
As of May 27
 +2.33 / +9.66%
Today’s Change
19.38
Today|||52-Week Range
74.10
-29.96%
Year-to-Date

Stock Price Forecast

The 15 analysts offering 12-month price forecasts for Axsome Therapeutics Inc have a median target of 62.00, with a high estimate of 180.00 and a low estimate of 27.00. The median estimate represents a +134.32% increase from the last price of 26.46.

Analyst Recommendations

The current consensus among 15 polled investment analysts is to Buy stock in Axsome Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$1.05
Sales
$3.7M
Reporting Date
Aug 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -2.10%
 
 
 
 
 
 
Growthannually -20.29%
 
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.